Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease
American Journal of Hematology · 2024-11 · 99 (11) · 2164-2177
DOI: 10.1002/ajh.27440 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift American Journal of Hematology, online erschienen am 22.07.2024. Verfasst von Ashutosh Lal und 5 weiteren Autor:innen. Beteiligte Einrichtung: University of California-San Francisco School of Medicine, Pediatric Hematology, Oakland, California, USA. Hauptthemen laut MEDLINE: alpha-Thalassemia. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 86 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Alpha‐thalassemia is an inherited blood disorder caused by impaired α‐globin chain production, leading to anemia and other complications. Hemoglobin H (HbH) disease is caused by a combination of mutations generally affecting the expression of three of four α‐globin alleles; disease severity is highly heterogeneous, largely driven by genotype. Notably, non‐deletional mutations cause a greater degree of ineffective erythropoiesis and hemolysis, higher transfusion burden, and increased complication risks versus deletional mutations. There are limited treatment options for HbH disease, and effective therapies are needed. This review discusses the pathophysiology of HbH disease, current management strategies, unmet needs, and emerging treatment options.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- University of California-San Francisco School of Medicine, Pediatric Hematology, Oakland, California, USA.
- Department of Pediatrics & Thalassemia Center, Siriraj Research Hospital, Mahidol University, Bangkok, Thailand.
- Department of Hematology, First Affiliated Hospital of Guangxi Medical University, Nanning, China.
- Department of Paediatrics, National Taiwan University Hospital, Taipei, Taiwan.
- First Department of Pediatrics, National and Kapodistrian University of Athens, Athens, Greece.
ORCID-Profile: Ashutosh Lal, Yongrong Lai
Zitieren
APA
Lal, A., Viprakasit, V., Vichinsky, E., Lai, Y., Lu, M. Y., & Kattamis, A. (2024). Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease. American Journal of Hematology, 99(11), 2164-2177. https://doi.org/10.1002/ajh.27440
Vancouver
Lal A, Viprakasit V, Vichinsky E, Lai Y, Lu MY, Kattamis A. Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease. American Journal of Hematology. 2024;99(11):2164-2177. doi:10.1002/ajh.27440
BibTeX
@article{Lal2024,
author = {Lal, Ashutosh and Viprakasit, Vip and Vichinsky, Elliott and Lai, Yongrong and Lu, Meng-Yao and Kattamis, Antonis},
title = {Disease burden, management strategies, and unmet needs in α‐thalassemia due to hemoglobin H disease},
journal = {American Journal of Hematology},
year = {2024},
volume = {99},
number = {11},
pages = {2164--2177},
doi = {10.1002/ajh.27440}
}
EUVIMED